Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-02 @ 3:41 AM
Study NCT ID:
NCT02261220
Status:
COMPLETED
Last Update Posted:
2020-03-06
First Post:
2014-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-02
First Submit QC Date:
None
Study First Post Date:
2014-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-05
Last Update Post Date:
2020-03-06
Last Update Post Date Type:
ACTUAL